CHD1 and posterior cortical atrophy: Such observations indicate not only the prognostic role of CHD1 deletion but also the therapeutic potential of such a “genetic handicap” and thereby support the rationale for therapeutic targeting of DNA-repair defects in CHD1-deleted PCa.